BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
Nature Genetics2014Vol. 47(1), pp. 22–30
Citations Over TimeTop 10% of 2014 papers
ICGC Project on Early Onset Prostate Cancer, Lei Gu, Sandra C. Frommel, Christopher C. Oakes, Ronald Simon, Katharina Grupp, Cristina Yasoma Gerig, Dominik Bär, Mark D. Robinson, Constance Baer, Melanie Weiß, Zuguang Gu, Matthieu Schapira, Ruprecht Kuner, Holger Sültmann, Maurizio Provenzano, Marie‐Laure Yaspo, Benedikt Brors, Jan O. Korbel, Thorsten Schlomm, Guido Sauter, Roland Eils, Christoph Plass, Raffaella Santoro
Related Papers
- → Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31(2014)86 cited
- → ETS fusion genes in prostate cancer(2014)80 cited
- → Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer(2015)69 cited
- → Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium(2016)15 cited
- → A computational bioinformatics analysis of gene expression identifies candidate agents for prostate cancer(2013)11 cited